Skip to search formSkip to main contentSkip to account menu

HIV Protease Inhibitors [MoA]

Known as: HIV Protease Inhibitors, Human Immunodeficiency Virus Protease Inhibitors 
National Institutes of Health

Related topics

Related topics

27 relations
AmprenavirAtazanavirAtazanavir sulfateErgotamine

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2011
Review
2011
[Vitamin D and drugs].
Interactions between drugs and vitamin D have received only little or no attention in the medical and pharmaceutical world in the… 
2010
2010
Espectrofotometria derivada: uma contribuição prática para o desenvolvimento de métodos
A espectrofotometria derivada (ED) tem sido utilizada como uma importante ferramenta no controle de qualidade de medicamentos… 
2009
2009
Quantification of HIV protease inhibitors and non-nucleoside reverse transcriptase inhibitors in peripheral blood mononuclear cell lysate using liquid chromatography coupled with tandem mass…
2009
2009
2-Pyridyl P1'-substituted symmetry-based human immunodeficiency virus protease inhibitors (A-792611 and A-790742) with potential for convenient dosing and reduced side effects.
A series of symmetry-based HIV protease inhibitors was designed and synthesized. Modification of the core regiochemistry and… 
2008
2008
Pharmacokinetics and Pharmacodynamics of Sildenafil in a Patient Treated With Human Immunodeficiency Virus Protease Inhibitors
We describe a 44-year-old male patient with human immunodeficiency virus (HIV) infection and pulmonary arterial hypertension who… 
2001
2001
Therapeutic Drug Monitoring of HIV Protease Inhibitors Using High-Performance Liquid Chromatography With Ultraviolet or Photodiode Array Detection
Published data suggest that therapeutic drug monitoring of human immunodeficiency virus protease inhibitors would improve the… 
2001
2001
Pharmacokinetic Study of Human Immunodeficiency Virus Protease Inhibitors Used in Combination with Amprenavir
ABSTRACT In an open-label, randomized, multicenter, multiple-dose pharmacokinetic study, we determined the steady-state… 
2000
2000
In vitro activity of human immunodeficiency virus protease inhibitors against Pneumocystis carinii.
Since 1996, the introduction of protease inhibitors (PIs) has led to a dramatic decrease of human immunodeficiency virus-related… 
1998
1998
Localized adipose tissue hypertrophy in patients receiving human immunodeficiency virus protease inhibitors.
1998
1998
Simultaneous determination of ritonavir and saquinavir, two human immunodeficiency virus protease inhibitors, in human serum by high-performance liquid chromatography.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)